CD4-话题@MedSci

#CD4#

117篇内容 | 3236人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1864270, encodeId=4eb518642e0c2, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Blood：CD49d促进慢性淋巴细胞白血病进展, objectType=article, longId=187614, objectId=364e18e61427, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=364e18e61427, replyNumber=0, likeNumber=107, createdTime=2020-03-17, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=364e18e61427, moduleTitle=Blood：CD49d促进慢性淋巴细胞白血病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=364e18e61427)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864268, encodeId=5909186426823, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Blood：在GVHD过程中，Bhlhe40+ GM-CSF+ CD4+ T细胞促进胃肠道间接抗原提呈, objectType=article, longId=185543, objectId=f4821855437d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4821855437d, replyNumber=0, likeNumber=0, createdTime=2020-06-13, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4821855437d, moduleTitle=Blood：在GVHD过程中，Bhlhe40+ GM-CSF+ CD4+ T细胞促进胃肠道间接抗原提呈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4821855437d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864260, encodeId=93e71864260f2, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=J Cancer Res Clin Oncol：CD44剪接变异（CD44v3）能够促进膀胱上皮肿瘤恶化, objectType=article, longId=181098, objectId=edd718109852, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edd718109852, replyNumber=0, likeNumber=73, createdTime=2020-07-27, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edd718109852, moduleTitle=J Cancer Res Clin Oncol：CD44剪接变异（CD44v3）能够促进膀胱上皮肿瘤恶化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edd718109852)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864271, encodeId=ae4b18642e116, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=吉利德以49亿美元全现金收购Forth Seven公司，获得靶向CD47免疫检查点的癌症免疫疗法, objectType=article, longId=189497, objectId=cf0d18949e12, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf0d18949e12, replyNumber=0, likeNumber=94, createdTime=2020-04-15, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf0d18949e12, moduleTitle=吉利德以49亿美元全现金收购Forth Seven公司，获得靶向CD47免疫检查点的癌症免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf0d18949e12)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864277, encodeId=81ba18642e7ec, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Diabetologia：1型糖尿病的GAD-alum免疫疗法可扩展双功能Th1 / Th2自反应性CD4 T细胞, objectType=article, longId=198184, objectId=28d919818401, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28d919818401, replyNumber=0, likeNumber=49, createdTime=2021-03-07, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28d919818401, moduleTitle=Diabetologia：1型糖尿病的GAD-alum免疫疗法可扩展双功能Th1 / Th2自反应性CD4 T细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28d919818401)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864274, encodeId=cab918642e4b7, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Sci Rep：肾肿瘤CD105−/CD44−细胞具有干细胞特性并能够在体内形成恶性肿瘤 , objectType=article, longId=192398, objectId=aa4719239878, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa4719239878, replyNumber=0, likeNumber=67, createdTime=2020-06-19, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa4719239878, moduleTitle=Sci Rep：肾肿瘤CD105−/CD44−细胞具有干细胞特性并能够在体内形成恶性肿瘤 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa4719239878)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864261, encodeId=ad86186426156, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Gastric Cancer：血液和骨髓中角蛋白阳性CD44 +肿瘤细胞与胃癌患者预后不良相关, objectType=article, longId=181679, objectId=b7281816e98c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7281816e98c, replyNumber=0, likeNumber=62, createdTime=2020-02-24, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7281816e98c, moduleTitle=Gastric Cancer：血液和骨髓中角蛋白阳性CD44 +肿瘤细胞与胃癌患者预后不良相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7281816e98c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864272, encodeId=912418642e290, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=JEM：肠道微生物助力CD47抑制剂对抗肿瘤, objectType=article, longId=189598, objectId=b71618959810, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b71618959810, replyNumber=0, likeNumber=78, createdTime=2020-05-09, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b71618959810, moduleTitle=JEM：肠道微生物助力CD47抑制剂对抗肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b71618959810)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864267, encodeId=369f186426eba, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=J hepatology： HBV特异性CD4 T细胞的TNF-α/IFN-γ谱与慢性HBV感染中的肝损伤和病毒清除有关, objectType=article, longId=185403, objectId=2cf518540350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cf518540350, replyNumber=0, likeNumber=77, createdTime=2020-01-22, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cf518540350, moduleTitle=J hepatology： HBV特异性CD4 T细胞的TNF-α/IFN-γ谱与慢性HBV感染中的肝损伤和病毒清除有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cf518540350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864276, encodeId=bd2118642e68b, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=J Clin Periodontol：人牙周膜细胞和炎症环境介导维生素 D3 对CD4+T淋巴细胞的多效性, objectType=article, longId=195082, objectId=032019508269, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=032019508269, replyNumber=0, likeNumber=63, createdTime=2020-08-03, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=032019508269, moduleTitle=J Clin Periodontol：人牙周膜细胞和炎症环境介导维生素 D3 对CD4+T淋巴细胞的多效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=032019508269)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864273, encodeId=afd318642e3b4, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=J Exp Med：肠道微生物助力CD47抑制剂对抗肿瘤, objectType=article, longId=190594, objectId=85fe190594d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85fe190594d7, replyNumber=0, likeNumber=122, createdTime=2020-06-17, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85fe190594d7, moduleTitle=J Exp Med：肠道微生物助力CD47抑制剂对抗肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85fe190594d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864263, encodeId=9518186426304, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=我国首创的抗 PD-1/CD47双特异抗体新药HX009获得NMPA IND批准, objectType=article, longId=182513, objectId=6b6e182513de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b6e182513de, replyNumber=0, likeNumber=0, createdTime=2020-06-16, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b6e182513de, moduleTitle=我国首创的抗 PD-1/CD47双特异抗体新药HX009获得NMPA IND批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b6e182513de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864258, encodeId=61171864258c6, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Blood：靶向抑制CD47-SIRPα的治疗活性需要Fc-FcγR的相互作用, objectType=article, longId=177156, objectId=7f171e715695, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f171e715695, replyNumber=0, likeNumber=67, createdTime=2019-11-22, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f171e715695, moduleTitle=Blood：靶向抑制CD47-SIRPα的治疗活性需要Fc-FcγR的相互作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f171e715695)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864252, encodeId=4b83186425275, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=NEJM：CD4单抗UB-421用于HIV患者逆转录疗法停药的维持治疗, objectType=article, longId=164560, objectId=fb7b16456042, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb7b16456042, replyNumber=0, likeNumber=92, createdTime=2019-07-14, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb7b16456042, moduleTitle=NEJM：CD4单抗UB-421用于HIV患者逆转录疗法停药的维持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb7b16456042)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864266, encodeId=5abf186426689, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Lancet Oncol：CD4/6抑制剂用于激素受体阳性、HER2阴性转移性乳腺癌, objectType=article, longId=184893, objectId=50041848939a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50041848939a, replyNumber=0, likeNumber=86, createdTime=2020-05-15, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50041848939a, moduleTitle=Lancet Oncol：CD4/6抑制剂用于激素受体阳性、HER2阴性转移性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50041848939a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864254, encodeId=29081864254d3, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=2019 ATC：诺华的抗CD40单抗iscalimab可提高肾移植的耐受性并改善长期预后, objectType=article, longId=168059, objectId=552b1680597c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=552b1680597c, replyNumber=0, likeNumber=70, createdTime=2019-12-05, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=552b1680597c, moduleTitle=2019 ATC：诺华的抗CD40单抗iscalimab可提高肾移植的耐受性并改善长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=552b1680597c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864256, encodeId=b533186425689, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=晚期恶性肿瘤的治疗：抗CD47单克隆抗体TJC4在中国启动临床试验, objectType=article, longId=175549, objectId=7fc31e5549df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fc31e5549df, replyNumber=0, likeNumber=66, createdTime=2020-05-28, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fc31e5549df, moduleTitle=晚期恶性肿瘤的治疗：抗CD47单克隆抗体TJC4在中国启动临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fc31e5549df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864255, encodeId=b78f18642553b, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=2019 EHA：TG Therapeutics的抗CD47 / CD19双特异性抗体TG-1801临床前抗淋巴瘤作用显著, objectType=article, longId=168714, objectId=1c1a168e1418, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c1a168e1418, replyNumber=0, likeNumber=71, createdTime=2019-11-03, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c1a168e1418, moduleTitle=2019 EHA：TG Therapeutics的抗CD47 / CD19双特异性抗体TG-1801临床前抗淋巴瘤作用显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c1a168e1418)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864262, encodeId=9f64186426253, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Cell |阐明CD4+ T细胞的嘌呤合成紊乱与压力引发的焦虑症间的重要联系, objectType=article, longId=182242, objectId=00ff182242b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00ff182242b8, replyNumber=0, likeNumber=78, createdTime=2019-12-24, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00ff182242b8, moduleTitle=Cell |阐明CD4+ T细胞的嘌呤合成紊乱与压力引发的焦虑症间的重要联系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00ff182242b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1864257, encodeId=4503186425ee6, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, objectTitle=Gastric Cancer：血液和骨髓中的CD44 +细胞角蛋白阳性肿瘤细胞与胃癌患者的预后不良相关, objectType=article, longId=176900, objectId=6a0e1e69005a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a0e1e69005a, replyNumber=0, likeNumber=49, createdTime=2020-03-21, rootId=0, userName=qidongfanjian, userId=b09892, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a0e1e69005a, moduleTitle=Gastric Cancer：血液和骨髓中的CD44 +细胞角蛋白阳性肿瘤细胞与胃癌患者的预后不良相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a0e1e69005a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CD4

2020-05-29

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Blood：CD49d促进慢性淋巴细胞白血病进展

2020-03-17

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Blood：在GVHD过程中，Bhlhe40+ GM-CSF+ CD4+ T细胞促进胃肠道间接抗原提呈

2020-06-13

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

J Cancer Res Clin Oncol：CD44剪接变异（CD44v3）能够促进膀胱上皮肿瘤恶化

2020-07-27

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

吉利德以49亿美元全现金收购Forth Seven公司，获得靶向CD47免疫检查点的癌症免疫疗法

2020-04-15

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Diabetologia：1型糖尿病的GAD-alum免疫疗法可扩展双功能Th1 / Th2自反应性CD4 T细胞

2021-03-07

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Sci Rep：肾肿瘤CD105−/CD44−细胞具有干细胞特性并能够在体内形成恶性肿瘤

2020-06-19

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Gastric Cancer：血液和骨髓中角蛋白阳性CD44 +肿瘤细胞与胃癌患者预后不良相关

2020-02-24

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

JEM：肠道微生物助力CD47抑制剂对抗肿瘤

2020-05-09

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

J hepatology： HBV特异性CD4 T细胞的TNF-α/IFN-γ谱与慢性HBV感染中的肝损伤和病毒清除有关

2020-01-22

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

J Clin Periodontol：人牙周膜细胞和炎症环境介导维生素 D3 对CD4+T淋巴细胞的多效性

2020-08-03

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

J Exp Med：肠道微生物助力CD47抑制剂对抗肿瘤

2020-06-17

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

我国首创的抗 PD-1/CD47双特异抗体新药HX009获得NMPA IND批准

2020-06-16

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Blood：靶向抑制CD47-SIRPα的治疗活性需要Fc-FcγR的相互作用

2019-11-22

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

NEJM：CD4单抗UB-421用于HIV患者逆转录疗法停药的维持治疗

2019-07-14

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Lancet Oncol：CD4/6抑制剂用于激素受体阳性、HER2阴性转移性乳腺癌

2020-05-15

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

2019 ATC：诺华的抗CD40单抗iscalimab可提高肾移植的耐受性并改善长期预后

2019-12-05

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

晚期恶性肿瘤的治疗：抗CD47单克隆抗体TJC4在中国启动临床试验

2020-05-28

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

2019 EHA：TG Therapeutics的抗CD47 / CD19双特异性抗体TG-1801临床前抗淋巴瘤作用显著

2019-11-03

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Cell |阐明CD4+ T细胞的嘌呤合成紊乱与压力引发的焦虑症间的重要联系

2019-12-24

qidongfanjian (审核中...)

前往app查看评论内容

#CD4#

Gastric Cancer：血液和骨髓中的CD44 +细胞角蛋白阳性肿瘤细胞与胃癌患者的预后不良相关

2020-03-21

科室
- - 订阅+
  - 更多科室
工具
服务